IJCRR - 10(6), March, 2018
Pages: 37-42
Effect of Duration of Diabetes on Heart Rate Variability in Type 2 Diabetes Mellitus
Author: Amina Sultan Zaidi, P. N. Singh, Meenakshi Gupta, Sheelu Shafiq Siddiqi
Category: Healthcare
[Download PDF]
Abstract:
Introduction: Diabetes is a metabolic disorder with debilitating complications which affects several million people worldwide. Cardiac Autonomic Neuropathy (CAN) is the most common chronic complication of type 2 diabetes mellitus (T2DM), which is concealed for long period of disease. Heart rate variability (HRV) test is the simple and sensitive test for CAN. Diagnosing CAN at subclinical stage and knowing the correlation of HRV with duration of diabetes can help to prevent the morbidity and mortality because of this neuropathy.
Objective: This study aims to determine the correlation of HRV with duration of diabetes in type 2 diabetes mellitus.
Materials and Methods: This cross sectional study was conducted in Department of Physiology, in collaboration with Rajeev Gandhi Centre for Diabetes and Endocrinology on patients of T2DM attending Diabetes clinic in Jawaharlal Nehru Medical college hospital (JNMCH), AMU, Aligarh, from 2014 to 2016 after approval from the ethical committee of J. N. Medical College. Total 90 subjects were taken, among whom 60 subjects were diagnosed cases of T2DM, which were divided in two groups on the basis of duration of diabetes. Rest 30 subjects were non diabetic control group. For CAN heart rate variability test was done.
Statistical analysis was performed using SPSS version 21.0.
Results: In shorter duration Diabetes (3.31 ± 1.72 years T2DM), significant (p value<0.05) negative correlation was seen between duration of diabetes and pNN50, RMSSD, HF power and LF/HF ratio, while in longer duration of Diabetes (12 ± 4.42 years T2DM), there was significant (p value<0.05) negative correlation between duration of diabetes and all four HRV parameters, namely, pNN50, RMSSD, HF power, LF power, LF/HF ratio.
Conclusion: Chronic hyperglycemia in diabetes leads to the degeneration and damage of autonomic nerves.
Keywords: Cardiac Autonomic Neuropathy, Chronic hyperglycemia, Low frequency power, High frequency power
DOI: 10.7324/IJCRR.2018.1068
Citation:
Amina Sultan Zaidi, P. N. Singh, Meenakshi Gupta, Sheelu Shafiq Siddiqi. Effect of Duration of Diabetes on Heart Rate Variability in Type 2 Diabetes Mellitus International Journal of Current Research and Review. 10(6), March, 37-42
References:
[1]Fauci, A S, Braunwald E, Kasper D L, Hauser S L, Longo Dan L, Jameson J Larry (2008). Harrison's Principle of Internal Medicine 17 Edition.
[2] International Diabetes Federation. IDF diabetes atlas. 6th Brussels: International Diabetes Federation, 2013.
[3] Fauci, A S, Braunwald E, Kasper D L, Hauser S L, Longo Dan L, Jameson J Larry (2008). Harrison's Principle of Internal Medicine 17 Edition
[4] A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman, “Diabetic autonomic neuropathy‚“ Diabetes Care, vol. 26, no. 5, pp. 1553–1579, 2003.
[5] R. E. Maser and M. J. Lenhard,‚“Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment,”Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 10, pp. 5896–5903, 2005
[6] R. E. Maser, B. D. Mitchell, A. I. Vinik, and R. Freeman, “The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes a meta-analysis,” Diabetes Care, vol. 26, no. 6, pp. 1895–1901, 2003
[7] S. Tesfaye, A. J. M. Boulton, P. J. Dyck et al., “Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments,” Diabetes Care, vol. 33, no. 12, pp. 2285–2293, 2010.
[8]. American Diabetes Association, Diabetes Care 2015 Jan; 38 (Supplement 1); S8-S16
[9]. Kahn CR. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994. Aug?43(8):10661084.
[10]. Robertson RP. Antagonist: diabetes and insulin resistance-philosophy, science, and the multiplier hypothesis. J Lab Clin Med 1995. May?125(5):560564, discussion 565.
[11] Task Force of the European Society of Cardiology and North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurements, physiological interpretation and clinical use. Circulation 1996; 93:1043–1065,
[12]. Acharya R, Hegde BM, Bhat PS, Rao A and Niranjan UC; Heart rate variability: a review. Med BiolEngComput.2006 Dec;44(12):1031-51. Epub 2006 Nov 17.
[1]]. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat to beat cardiovascular control. Science.1981;213:220-222
[14]. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, LloydJones
DM, et al. Association of hyperglycemia with reduced heart rate variability: The Framingham Heart Study. Am J Cardiol 2000?86:30912.
[15]. Kudat H, Akkaya V, Sozen AB, Salman S, Demirel S, Ozcan M, Atilgan D, Yilmaz MT, Guven O “Heart rate variability in diabetes patient” The Journal of International Medical Research 2006; 34: 291 – 296.
[16]. Spallone V, Bernardi L, Maiello MR, Cicconetti E, Ricordi L, Fratino P, Menzinger G Twenty-four-hour pattern of blood pressure and spectral analysis of heart rate variability in diabetic patients with various degrees of autonomic neuropathy. Comparison to standard cardiovascular tests; ClinSci(Lond). 1996; 91 Suppl: 1057.
[17] Neil HA, Thompson AV, John S, McCarthy ST, Mann JI. Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diabetic medicine : a journal of the British Diabetic Association. 1989;6(1):20-4.
[18]Murata K, Sumida Y, Murashima S, Matsumura K, Takeda H, Nakagawa T, et al. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Diabetic medicine: a journal of the British Diabetic Association. 1996; 13(3):266-72. Epub1996/03/01.doi: 10.1002/(SICI)1096-9136(199603)13:3<266::AIDDIA72> 3.0.CO;2-4.
|